J. Skrha et al., COMPARISON OF INSULIN SENSITIVITY IN PATIENTS WITH INSULINOMA AND OBESE TYPE-2 DIABETES-MELLITUS, Hormone and Metabolic Research, 28(11), 1996, pp. 595-598
Insulin sensitivity was evaluated in 16 insulinoma patients and in 15
obese persons with Type 2 diabetes mellitus by using hyperinsulinaemic
clamps and analysis of insulin receptor characteristics on erythrocyt
es. Significantly decreased insulin sensitivity index (M/I) was found
in both insulinoma and obese Type 2 diabetic patients as compared with
healthy non-obese controls (21.2+/-2.2 and 19.5+/-2.6 vs 40.3+/-3.7 m
u mol . kg(-1) min(-1) per mU . l(-1) x 100, p<0.001). No difference w
as observed between both groups of patients. Metabolic clearance rate
of glucose was strongly reduced in obese diabetic patients but it was
normal in insulinoma patients in comparison with healthy persons (2.7
+/- 0.4 vs 8.7+/-0.6 or 7.9+/-0.7 ml . kg(-1) . min(-1), p<0.001). A d
ecreased insulin binding on specific receptors caused by reduced bindi
ng capacity was observed only in insulinoma patients but not in obese
Type 2 diabetic patients. A significant negative correlation was prove
d between body mass index (BMI) and insulin sensitivity index (r = -0.
82, p<0.001) indicating that BMI is the main determining factor of ins
ulin resistance in the total cohort of examined patients. We conclude
that insulin resistance was caused by postreceptor changes in obese Ty
pe 2 diabetes, whereas a decreased insulin binding capacity together w
ith postreceptor defect was present in insulinoma patients.